menaquinone-6 has been researched along with 1-octacosanol* in 1 studies
1 trial(s) available for menaquinone-6 and 1-octacosanol
Article | Year |
---|---|
Supplementation with Octacosanol Affects the Level of PCSK9 and Restore Its Physiologic Relation with LDL-C in Patients on Chronic Statin Therapy.
Dietary supplementation with sugar cane derivates may modulate low-density lipoprotein cholesterol (LDL-C) and proprotein convertase subtilisin/kexin type 9 (PCSK9) levels. The purpose of this study was to determine if dietary supplement (DS), containing Octacosanol (20 mg) and vitamin K2 (45 µg), could restore the disrupted physiologic relation between LDL-C and serum PCSK9. Double-blind, randomized, placebo-controlled, single-center study including 87 patients on chronic atorvastatin therapy was conducted. Eighty-seven patients were randomized to receive DS ( Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Dyslipidemias; Fatty Alcohols; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Proprotein Convertase 9; Vitamin K 2; Vitamins | 2021 |